CCT3 promotes tumor progression through multiple signaling pathways and is linked to immune cell infiltration and immune checkpoint expression in the tumor microenvironment, presenting a new potential target for overcoming drug resistance in various cancers. Here, CCT3 is linked to neoplasm.